Cargando…
SMAGP a novel biomarker of cervical cancer development and progression
INTRODUCTION: Cervical cancer, one of the most common malignant gynecological tumors, is a significant burden on the health of females worldwide. The purpose of this study was to investigate genes associated with lymph node metastasis in cervical cancer. METHODS: We report on the lymph node metastas...
Autores principales: | Jia, Yongqin, Li, Haiyu, Liu, Geli, Song, Fangzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199232/ https://www.ncbi.nlm.nih.gov/pubmed/30410350 http://dx.doi.org/10.2147/OTT.S175808 |
Ejemplares similares
-
SMAGP a Novel Biomarker of Cervical Cancer Development and Progression [Erratum]
Publicado: (2020) -
LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway
por: Li, Haiyu, et al.
Publicado: (2018) -
ARHGEF38 as a novel biomarker to predict aggressive prostate cancer
por: Liu, Kun, et al.
Publicado: (2019) -
FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway
por: Rong, Li, et al.
Publicado: (2020) -
HIV-1-infected cell-derived exosomes promote the growth and progression of cervical cancer
por: Li, Haiyu, et al.
Publicado: (2019)